Jiangsu Recbio Technology Co., Ltd. (HKG:2179)
Hong Kong · Delayed Price · Currency is HKD 5.00
0.00 (0.00%)
Sep 4, 2026, 9:15 AM HKT
Jiangsu Recbio Technology Market Cap
Jiangsu Recbio Technology has a market cap or net worth of 3.02 billion as of September 11, 2026. Its market cap has decreased by -14.93% in one year.
Market Cap
3.02B
Enterprise Value
3.58B
Revenue
568.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
5.00
ChartMarket Cap Chart
Since March 31, 2022, Jiangsu Recbio Technology's market cap has decreased from 12.10B to 3.02B, a decrease of -75.02%. That is a compound annual growth rate of -26.78%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 10, 2026 | 3.02B | 22.50% |
| Dec 31, 2025 | 2.47B | -45.80% |
| Dec 31, 2024 | 4.55B | -12.74% |
| Dec 29, 2023 | 5.22B | -56.10% |
| Dec 30, 2022 | 11.88B | -1.79% |
| Mar 31, 2022 | 12.10B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| TransThera Sciences (Nanjing) | 3.95B |
| Qyuns Therapeutics | 3.69B |
| Mirxes Holding Company | 3.66B |
| HJ Science | 3.31B |
| BioDlink International Company | 2.91B |
| Laekna | 2.87B |
| Clover Biopharmaceuticals | 2.84B |
| Medtide | 2.84B |